There’s a lot to be optimistic about in the Technology sector as 3 analysts just weighed in on Apple (AAPL – Research Report), Zscaler (ZS – Research Report) and Sprinklr (CXM – Research Report) with bullish sentiments.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Apple (AAPL)
Wedbush analyst Daniel Ives maintained a Buy rating on Apple yesterday and set a price target of $220.00. The company’s shares closed last Friday at $157.37.
According to TipRanks.com, Ives is a 5-star analyst with an average return of
Apple has an analyst consensus of Strong Buy, with a price target consensus of $183.56, a 18.1% upside from current levels. In a report issued on September 8, Needham also maintained a Buy rating on the stock with a $170.00 price target.
See today’s best-performing stocks on TipRanks >>
Zscaler (ZS)
JMP Securities analyst Trevor J. Walsh maintained a Buy rating on Zscaler on September 9 and set a price target of $280.00. The company’s shares closed last Friday at $188.00.
According to TipRanks.com, Walsh is a 1-star analyst with an average return of
Zscaler has an analyst consensus of Strong Buy, with a price target consensus of $214.40, a 22.5% upside from current levels. In a report issued on September 9, RBC Capital also maintained a Buy rating on the stock with a $210.00 price target.
Sprinklr (CXM)
JMP Securities analyst Patrick Walravens maintained a Buy rating on Sprinklr on September 9 and set a price target of $22.00. The company’s shares closed last Friday at $12.30.
According to TipRanks.com, Walravens is a 4-star analyst with an average return of
Currently, the analyst consensus on Sprinklr is a Moderate Buy with an average price target of $15.57, which is a 29.8% upside from current levels. In a report issued on September 9, Oppenheimer also maintained a Buy rating on the stock with a $16.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on AAPL:
- Analysts Offer Insights on Healthcare Companies: Immatics (IMTX), Biogen (BIIB) and Bicycle Therapeutics (BCYC)
- SVB Securities Reaffirms Their Hold Rating on Nektar Therapeutics (NKTR)
- Immunovant (IMVT) Receives a Buy from SVB Securities
- Maxim Group Sticks to Its Hold Rating for Adial Pharmaceuticals (ADIL)
- Fiverr International (FVRR) Gets a Buy from JMP Securities
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue